IRIS
BONGIOVANNI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 824
AS - Asia 540
EU - Europa 358
SA - Sud America 107
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 12
OC - Oceania 2
Totale 1.950
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 736
IT - Italia 319
SG - Singapore 165
CN - Cina 137
BR - Brasile 69
BD - Bangladesh 67
HK - Hong Kong 50
VN - Vietnam 33
CA - Canada 32
IN - India 21
MX - Messico 20
IQ - Iraq 13
CR - Costa Rica 10
AR - Argentina 9
VE - Venezuela 9
RU - Federazione Russa 8
CO - Colombia 7
JM - Giamaica 7
MY - Malesia 7
PH - Filippine 7
TR - Turchia 7
GT - Guatemala 6
ID - Indonesia 6
PK - Pakistan 6
FR - Francia 5
NL - Olanda 5
AE - Emirati Arabi Uniti 4
GB - Regno Unito 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
EC - Ecuador 3
ES - Italia 3
MA - Marocco 3
TT - Trinidad e Tobago 3
ZA - Sudafrica 3
BZ - Belize 2
CL - Cile 2
EG - Egitto 2
HN - Honduras 2
PL - Polonia 2
PR - Porto Rico 2
PY - Paraguay 2
RS - Serbia 2
SV - El Salvador 2
UA - Ucraina 2
UZ - Uzbekistan 2
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DE - Germania 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
IE - Irlanda 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 1.843
Salva come PNG Salva come JPEG
Città #
San Jose 331
Ashburn 114
Council Bluffs 106
Singapore 70
Beijing 56
Hong Kong 49
Milan 47
Rome 38
Naples 28
Mexico City 18
Santa Clara 18
New York 16
Phoenix 11
Figino 10
Ho Chi Minh City 10
Hanoi 9
Montreal 9
Turin 9
Florence 7
Baghdad 6
Bologna 6
Guatemala City 6
Los Angeles 6
Palermo 6
Bari 5
Catania 5
Medellín 5
San José 5
Buffalo 4
Dhaka 4
Kuala Lumpur 4
São Paulo 4
Toronto 4
Amsterdam 3
Brescia 3
Cagliari 3
Chandigarh 3
Chennai 3
Curitiba 3
Dallas 3
Delhi 3
Istanbul 3
Lima 3
Montesilvano 3
Mumbai 3
Ninh Bình 3
Nocera Terinese 3
Padua 3
Reggio Emilia 3
Afragola 2
Alajuela 2
Anchorage 2
Asunción 2
Belford Roxo 2
Belgrade 2
Brampton 2
Brasília 2
Campinas 2
Capaccio Paestum 2
Chicago 2
Córdoba 2
Da Nang 2
Eygelshoven 2
Genoa 2
Guarulhos 2
Havertown 2
Jacksonville 2
Karbala 2
Kingston 2
Mariglianella 2
Miami 2
Midrand 2
Minturno 2
Modena 2
Montes Claros 2
Monza 2
Moscow 2
Nashville 2
Newton 2
Pescara 2
Prato 2
Providence 2
Ribeirão Preto 2
Rimini 2
Riyadh 2
San Benedetto del Tronto 2
San Diego 2
San Francisco 2
San Giovanni la Punta 2
San Polo di Piave 2
San Salvador 2
Santiago 2
Selçuklu 2
Tashkent 2
Toledo 2
Toritto 2
Trieste 2
Verona 2
Vicenza 2
Villacidro 2
Totale 1.176
Salva come PNG Salva come JPEG
Nome #
mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model 149
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 32
Activity of Eribulin in a primary culture of well-differentiated/dedifferentiated adipocytic sarcoma 30
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 26
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin 26
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line 25
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences 25
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 24
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 24
A biomimetic 3D model of hypoxia-driven cancer progression. 24
3-T magnetic resonance-guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors. 23
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509) 23
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel 23
“Cytokine gene polymorphisms and breast cancer susceptibility” 23
111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: Its accuracy and prognostic significance 22
Immunotherapy in malignant pleural mesothelioma: a long story ended in success 22
Peptide receptor radionuclide therapy with177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and18F-FDG PET 22
BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center "Real-Life" Experience (BOHEME Study) 22
DLL3 expression in neuroendocrine carcinomas: a comparative analysis across tumor origins 22
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas 21
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis 21
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials 21
Third- and further-line therapy in advanced non-small-cell lung cancer patients: An overview 21
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma 21
Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture 21
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort 21
Development of a human preclinical model of osteoclastogenesis from peripheral blood monocytes co-cultured with breast cancer cell lines 21
Drug-loaded biomorphic scaffolds for tissue regeneration and targeted antitumor therapy in bone metastasis models 20
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature 20
Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy. 20
Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine. 20
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: A case report 20
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study 20
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)” 20
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations 19
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: Efficacy profile, safety, and quality of life 19
High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literature 19
temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A "Real-World" Data Analysis. Neuroendocrinology. 19
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems 19
Establishment of a primary culture of patient-derived soft tissue sarcoma 19
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR) 19
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors. 19
Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis 19
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational 19
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index 19
Myxofibrosarcoma primary cultures: molecular and pharmacological profile 19
Ten-year experience of the multidisciplinary Osteoncology Center 18
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 18
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE 18
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway 18
Comment on 'Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey' by Alice Indini et al. 18
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas 18
Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas 18
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 18
Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age 17
Clinical and translational implications of immunotherapy in sarcomas 17
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio. 17
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: Case report 16
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis 16
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 16
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas 16
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. 15
Abstract 333: Development of a biomimetic 3D scaffold to study breast cancer bone metastasis 15
Outcomes of platinum-sensitive small-cell lung cancer patients treated with platinum/etoposide rechallenge: A multi-institutional retrospective analysis 15
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives. 15
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis 15
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 15
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models. 15
Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet 15
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors 15
Innovative approaches to establish and characterize primary cultures: An ex vivo 3D system and the zebrafish model 15
Primary leiomyosarcoma of the bone: A case report and a review of the literature 15
First prospective data on breast cancer patients from the multicentre italian bone metastasis database 15
Editorial: From bench to bedside in gastric cancer: diagnosis, prognosis, and treatment, volume II 14
Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: An updated network meta-analysis 14
Management and potentialities of primary cancer cultures in preclinical and translational studies 14
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis 14
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18FDG-PET/CT 14
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study” 14
Belzutifan for Advanced Pheochromocytoma or Paraganglioma 13
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: A suitable regimen and review of the literature 13
Dried blood and serum spots as a useful tool for sample storage to evaluate cancer biomarkers 13
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. 13
The effect of everolimus in an in vitro model of triple negative breast cancer and osteoclasts 13
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma” 13
Identification of a novel RAB3IP-HMGA2 fusion transcript in an adult head and neck rhabdomyosarcoma 13
Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a Zebrafish model 13
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin 13
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer 13
RANKL: A promising circulating marker for bone metastasis response 12
Therapeutic strategies in advanced pheochromocytoma or paraganglioma 12
Single bone metastasis from adenocarcinoma of the lacrimal gland: A case report 12
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities. 12
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 12
Comment on the Paper by Lemelin et al. Entitled "Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study". 12
Bocchini M, Nicolini F, Severi S, Bongiovanni A, Ibrahim T, Simonetti G, Grassi I, Mazza M. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review. 12
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials 12
Clinical role of filgrastim in the management of patients at risk of prolonged severe neutropenia: An evidence-based review 12
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer. 11
Theragnostic in neuroendocrine tumors. 11
Totale 1.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.258 0 0 47 109 232 24 29 103 512 112 59 31
2026/2027692 124 39 188 341 0 0 0 0 0 0 0 0
Totale 1.950